1Hanly JG.Assessment and imaging in cns lupus[J].Ann Rheum Dis,2005(Suppl Ⅲ):21.
2Steup-Beekman GM,Emmer BJ,Van der Grond J,et al.Unravelling the pathogenetic mechanisms leading to human neuropsychiatric sle[J].Ann Rheum Dis,2006(Suppl Ⅱ):65.
3Kowal C,DeGiorgio L,Lee JY,et al.Further evidence for antibody-mediated cns disease in lupus[J].Ann Rheum Dis,2005 (Suppl Ⅲ):22.
4Sato T,Fujii TY.Fujita Y,et al.Clinical significance of antiUlrnp antibodies in cerebrospinal fluid derived from patients with neuropsychiatric lupus[J].Ann Rheum Dis,2006(Suppl Ⅱ):358.
5Ostanek L,Honczarenko K,Brzosko M,et al.Antiphospholipid antibodies as a risk factor of neurological manifestations in patients with systemic lupus erythematosus[J].Ann Rheum Dis,2005 (Suppl Ⅲ):239.
6Kotulska AT,Kucharz EJ,Kopec MM,et al.Higher serum endostatin level in patients with systemic lupus erythematosus with neurological manifestations[J].Ann Rheum Dis2005(Suppl Ⅲ):233.
7Steup-Beekman GM,Emmer BJ,Steens SC,et al.Detection of changes in cns involvement in neuropsychiatric sle with magnetization transfer imaging[J].Ann Rheum Dis,2006(Suppl Ⅱ):359.
8Afeltra A,Amoroso A,Mitterhofer AP,et al.The 677C→T mutation in the methylene tetrahydrofolate reduetase (MTHFR) gene in epileptie patients affected by systemic lupus erythematosus.Seizure,2002,11:250-254.
9Rudolf P Jr,Skerenova M,Hybenova J,et al.Apolipoprotein E,polymorphism in patients with neuropsychiatric SLE.Clin Rheumatology.2004,23:97-101.
10Weiner SM,Klein R,Berg PA.A longitudinal study of autoantibodies against central nervous system tissue and gangliosides in connective tissue diseases.Rheumatol Int.2000,19:83-88.
